Prof. Dr. Matthias Emanuel LiechtiResearch group leader
Research group leader
Universitäres Zentrum für Zahnmedizin Basel UZB
Departement Pharmazeutische Wissenschaften
Matthias Liechti graduated form the Medical School, University of Zurich Switzerland in 1998. He was a postdoc at the Universits Hospital of Psychiatry Zurich in 1999-2000 where he studied the pharmacology of psychoactive drugs. He then trained in internal medicine at the University Hospital of Zurich and obtained his spezialization in internal medicine in 2004. From 2005–2007 he was a postdoctoral researcher at the Scripps Research Institute, La Jolla and at the University of California, San Diego (UCSD) and trained in behavioral pharmacology. In 2007 he also completed a Master in Advanced Studies in Clinical Research at UCSD. Since 2008 he works at the Division of Clinical Pharmacology at the University Hospital of Basel. Matthias Liechti is an attending physician at the hospital and head of the psychopharmacology research group at the Department of Biomedicine of the University Hospital. His scientific interest are mechanism of action of psychoactive drugs, psychostimulants, addiction, CNS drug development and translational research methodologies. Direct links to research: Pharmaceutical Sciences, Biomedicine and Universitaetsspital Basel.
|Differential effects of classic serotonergic hallucinogens: pharmacokinetics-pharmacodynamics, pharmaco-fMRI, and role of 5-HT2 receptors||Ongoing|
|Effects of psychoactive substances on emotion processing in humans: role of serotonin, dopamine and 5-HT2A receptors||Complete|
|The role of the dopamine/norepinephrine transporters (SLC6A3/2) and of genetic polymorphisms in the effects of MDMA (ecstasy)||Complete|